HUDDINGE, Sweden--(BUSINESS WIRE)-- Karo Bio AB and Zydus Cadila have agreed to extend their research collaboration with the purpose to discover and develop novel anti-inflammatory drug compounds which affect glucocorticoid receptors in a selective manner.
